Skip to main
University-wide Navigation

UK Study Shows FDA-approved Leukemia Drug May Help Treat Metastatic Melanoma

Building on these findings, Plattner and Markey oncologists are now collaborating with the pharmaceutical company Novartis to develop a Phase I clinical trial to test the safety and effectiveness of using nilotinib in relapsed melanoma patients.

Health Sciences Team Leading $2.5 Million Multi-Site Ankle Injury Research Project

A team of Health Sciences investigators are collaborating with military researchers at the Naval Health Research Center and faculty at the University of Virginia to find rehabilitative solutions for populations most at risk for chronic and future ankle injuries.

College of Pharmacy Receives $11.8 Million to Further Substance Use Disorder Research

The funding will further ongoing substance use disorder treatment research in collaboration with Sharon Walsh at the UK Center on Drug and Alcohol Research (CDAR) and Mei-Chuan Ko at the Wake Forest School of Medicine.

Cancer, COVID and the Kentucky Economy: How 'Sweet Annie' Could Make an Impact

Artemisia annua or "Sweet Annie" has been used as a medicinal herb for centuries. With potential to treat a variety of cancers & even COVID-19, this plant is more relevant than ever & UK is showing how we can take it from Kentucky fields to the lab to our patients.

Volunteers Needed for Survey on Sleep, Stress, Alcohol Use During COVID-19 Outbreak

UK researchers hope to gain a better understanding of the effects of COVID-19 on sleep and alcohol use so that we will be better prepared to prevent and treat psychological effects of COVID-19 pandemic or similar outbreaks in the future.

Researchers Publish Study Looking at Approaches to Better Treat Alzheimer's Disease

For the past several decades, much of the work to find a treatment for AD has been focused on eliminating those dreaded Aβ plaques, by assuming that memory could be restored by removing the plaques.

UK Sanders-Brown Center on Aging Facilitates First Participant in Worldwide Drug Study

This work is looking at a study medication, BAN2401, to determine if it can help prevent worsening memory and thinking among individuals who might be at risk for future decline. They are hoping it will ultimately help prevent Alzheimer’s disease.

UK Human Research Protection Program Receives Full AAHRPP Reaccreditation

The five-year reaccreditation process involved an AAHRPP application consisting of some 1,700 pages, completed by ORI staff, describing the HRPP at UK and culminated with a two-day site visit.

Artemisia Annua Could Be Promising Treatment for COVID-19

The new potential treatment has been added to the University of Kentucky’s innovative clinical trial for experimental COVID-19 therapies, which was launched by leaders from UK’s Markey Cancer Center, College of Medicine and College of Pharmacy in May.

UK College of Medicine, UK HealthCare Launch New START Trial to Assess COVID-19 Prevalence

Known as Serologic Testing to Accelerate Recovery and Transition (START), the study focuses on antibody testing to begin understanding how many people in the region may have already contracted and recovered from COVID-19.

Filter News